These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19274418)

  • 1. Rationale for anti-inflammatory therapy in dry eye syndrome.
    de Paiva CS; Pflugfelder SC
    Arq Bras Oftalmol; 2008; 71(6 Suppl):89-95. PubMed ID: 19274418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of anti-inflammatory therapy on the treatment of dry eye syndrome].
    Mrukwa-Kominek E; Rogowska-Godela A; Gierek-Ciaciura S
    Klin Oczna; 2007; 109(1-3):79-84. PubMed ID: 17687921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in dry eye.
    Stern ME; Pflugfelder SC
    Ocul Surf; 2004 Apr; 2(2):124-30. PubMed ID: 17216083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on dry eye disease molecular treatment: advances in drug pipelines.
    Colligris B; Crooke A; Huete-Toral F; Pintor J
    Expert Opin Pharmacother; 2014 Jul; 15(10):1371-90. PubMed ID: 24773445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TOPICAL ANTI-INFLAMMATORY AGENTS FOR DRY EYE DISEASE].
    Erdinest N; Solomon A
    Harefuah; 2019 Feb; 158(2):130-135. PubMed ID: 30779493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inhibitors for the treatment of dry eye syndrome.
    Rodríguez-Pomar C; Pintor J; Colligris B; Carracedo G
    Expert Opin Pharmacother; 2017 Dec; 18(17):1855-1865. PubMed ID: 29115899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular mechanisms of dry eye: from pathogenesis to treatment.
    Mantelli F; Massaro-Giordano M; Macchi I; Lambiase A; Bonini S
    J Cell Physiol; 2013 Dec; 228(12):2253-6. PubMed ID: 23696296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.
    Coursey TG; de Paiva CS
    Clin Ophthalmol; 2014; 8():1447-58. PubMed ID: 25120351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
    Stern ME; Beuerman RW; Fox RI; Gao J; Mircheff AK; Pflugfelder SC
    Cornea; 1998 Nov; 17(6):584-9. PubMed ID: 9820935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of dry eye: a twenty-five-year review.
    Pflugfelder SC; Solomon A; Stern ME
    Cornea; 2000 Sep; 19(5):644-9. PubMed ID: 11009316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of dry eye in the elderly patient.
    Foulks GN
    Drugs Aging; 2008; 25(2):105-18. PubMed ID: 18257598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of ocular dryness associated with Sjögren׳s syndrome.
    Ciurtin C; Ostas A; Cojocaru VM; Walsh SB; Isenberg DA
    Semin Arthritis Rheum; 2015 Dec; 45(3):321-7. PubMed ID: 26216545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.
    Barabino S; Chen Y; Chauhan S; Dana R
    Prog Retin Eye Res; 2012 May; 31(3):271-85. PubMed ID: 22426080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutical approach to dry eye syndrome].
    Babić GS; Zlatanović G; Jocić JD; Cekić S; Vujanović M
    Med Pregl; 2010; 63(11-12):793-800. PubMed ID: 21553457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research update of effectiveness and mechanism of essential fatty acids in treating dry eye].
    Liu Y; Liang QF
    Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):225-229. PubMed ID: 28316198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.